NZ603739A - Combination therapy with peptide epoxyketones - Google Patents
Combination therapy with peptide epoxyketonesInfo
- Publication number
- NZ603739A NZ603739A NZ603739A NZ60373909A NZ603739A NZ 603739 A NZ603739 A NZ 603739A NZ 603739 A NZ603739 A NZ 603739A NZ 60373909 A NZ60373909 A NZ 60373909A NZ 603739 A NZ603739 A NZ 603739A
- Authority
- NZ
- New Zealand
- Prior art keywords
- medicament
- combination therapy
- combination
- dexamethasone
- administering
- Prior art date
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N epoxyketone group Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000002648 combination therapy Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079156 Proteasome inhibitor Drugs 0.000 abstract 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 abstract 2
- 229960003957 dexamethasone Drugs 0.000 abstract 2
- 239000003207 proteasome inhibitor Substances 0.000 abstract 2
- 208000034578 Multiple myelomas Diseases 0.000 abstract 1
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical compound C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 abstract 1
- 229960004942 lenalidomide Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19694508P | 2008-10-21 | 2008-10-21 | |
| NZ59273109 | 2009-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ603739A true NZ603739A (en) | 2014-02-28 |
Family
ID=50624311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ603739A NZ603739A (en) | 2008-10-21 | 2009-10-21 | Combination therapy with peptide epoxyketones |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ603739A (en) |
-
2009
- 2009-10-21 NZ NZ603739A patent/NZ603739A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014002171A (en) | Combination treatments for hepatitis c. | |
| WO2013003629A3 (en) | Methods and compositions for inhibition of bone resorption | |
| WO2007143600A3 (en) | Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases | |
| TW200833663A (en) | Therapeutic agents | |
| TN2009000444A1 (en) | Combination therapy with a compound acting as a plateletadp receptor inhibitor | |
| MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
| TW200639159A (en) | Treatment of pain | |
| MX338554B (en) | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain. | |
| WO2009033732A3 (en) | Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent | |
| NZ714963A (en) | Compositions and methods for treating anemia | |
| WO2009039969A3 (en) | Use of a vla-4 inhibitor tetrapeptide, alone or in combination with bpp-b, as a therapeutic agent | |
| MX2011009709A (en) | Compounds for treating inflammation and pain. | |
| MX2013003060A (en) | Combination therapy for treating hcv infection. | |
| HK1176318A1 (en) | Injection device | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| WO2013028818A8 (en) | Pyrimido- pyridazinone compounds and use thereof | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| MX2009011900A (en) | Diabetic wound healing. | |
| WO2009129527A3 (en) | Baclofen formulation in a polyorthoester carrier | |
| WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
| WO2012012305A3 (en) | Combination therapy using a ruthenium complex | |
| MY173491A (en) | Therapeutic or prophylactic agent for biliary tract diseases | |
| TNSN08506A1 (en) | Substituted carboxamides | |
| TN2014000031A1 (en) | Use of organic compound for the treatment of noonan syndrome | |
| IN2012DN02816A (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 21 OCT 2016 BY CPA GLOBAL Effective date: 20140717 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2017 BY CPA GLOBAL Effective date: 20160909 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2018 BY CPA GLOBAL Effective date: 20170907 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2019 BY CPA GLOBAL Effective date: 20180907 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2020 BY CPA GLOBAL Effective date: 20190905 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2021 BY CPA GLOBAL Effective date: 20200904 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2022 BY CPA GLOBAL Effective date: 20210910 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2023 BY ANAQUA SERVICES Effective date: 20220921 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 OCT 2024 BY ANAQUA SERVICES Effective date: 20230921 |